AMGEN Inc
NASDAQ: AMGN
$263.86
Real Time Data Delayed 15 Min.
AMGN Articles
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
Last Updated:
Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap, Snap and Twitter.
Published:
Last Updated:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data has been compared with the previous report, and short interest in...
Published:
Last Updated:
The September 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
Monday's top analyst upgrades, downgrades and initiations included Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Edwards Lifesciences, Occidental Petroleum and Walt Disney.
Published:
Last Updated:
The August 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 study evaluating AMG 510 in...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Amgen, Bank of America, Box, Chico's FAS, Microsoft, Netflix, NXP Semiconductors, StoneCo and Tiffany.
Published:
Last Updated:
Many mergers have been announced or have closed, but just seven recent and pending deals have transformed how analysts and investors alike are having to view corporate America.
Published:
Last Updated:
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations for Tuesday included Amgen, BorgWarner, Chipotle Mexican Grill, Cree, Dollar General, Exelon, PDC Energy, Verizon Communications and Zynga.
Published:
Last Updated:
Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation to Celgene’s merger with Bristol-Myers Squibb.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations for Monday included Amgen, Aramark, Chevron, Deere, Exxon Mobile, Hecla Mining, Occidental Petroleum, Urban Outfitters and Whiting Petroleum.
Published:
Last Updated: